Security key
729139105
PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (PLRX)
CUSIP: 729139105
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 51,491,424
- Total 13F value
- $59,725,484
- Share change
- -6,348,732
- Put/Call ratio
- 81%
- SEC-reported price per share
- $1.16
- Number of holders
- 112
- Value change
- -$8,565,167
- Number of buys
- 52
- Number of sells
- 88
- Shares outstanding
- 61,907,011
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
112
Top holders
10
PLRX full security history
Ownership snapshot
Full 13F holder table
PLIANT THERAPEUTICS, INC. SEC filings
PLIANT THERAPEUTICS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of PLRX - PLIANT THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TANG CAPITAL MANAGEMENT LLC
Disclosed value leader
TANG CAPITAL MANAGEMENT LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 9.6%
13D/G row: TANG CAPITAL MANAGEMENT LLC
Showing 1-6 of 15 holder rows.
Quick read
TANG CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 9.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TANG CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership
Top 5
TANG CAPITAL MANAGEMENT LLC
9.6%
VANGUARD GROUP INC
4.9%
Redmile Group, LLC
4.8%
BlackRock, Inc.
3.4%
FMR LLC
0.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
9.6%
|
$9,198,699
5,859,044 shares
|
$0 | 03 Mar 2025 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
4.9%
from 13D/G
|
$4,501,677
3,334,575 shares
|
— | 31 Mar 2025 |
| Redmile Group, LLC |
13D/G
13F
Company
|
4.8%
|
$4,545,900
2,895,478 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
13D/G
Company
|
3.4%
from 13D/G
|
$7,076,375
5,241,759 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13D/G
|
0.2%
|
$207,230
131,993 shares
|
$0 | 28 Feb 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
13F
T. Rowe Price Associates, Inc. · Company
|
0.1%
|
$137,648
87,674 shares
|
$0 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
112
Shares
51,491,424
Rows available
112
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
138
Q2 2025 holders
112
Holder diff
-26
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|